Trials / Completed
CompletedNCT03682354
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
Erector Spinae Plane Block Versus Intercostal Nerve Block Combined With Patient-controlled Intravenous Analgesia in Video-assisted Thoracic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A randomized prospective trial to test the non-inferiority of erector spinae plane block (ESPB) in comparison with intercostal nerve block combined with patient-controlled intravenous analgesia in Thoracoscopic lung surgery
Detailed description
For patients undergoing thoracic surgery, postoperative pain greatly limited their recovery.Multimodal analgesia have shown good efficacy but without reaching full pain relief. The primary goal of this study is to observe the effect of ultrasound-guided erector spinae plane block in comparison with intercostal nerve block combined with patient-controlled intravenous analgesia in video assisted thoracic lung surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intercostal Nerve Block with PCIA | Intercostal nerve block consists in the injection of Ropivacaine (4 ml,0.5%) in related intercostal spaces. Patient-controlled intravenous analgesia regimen is conducted with sufentanil. |
| DRUG | Erector Spinae Plane Block (ESPB) | Erector Spinae Plane Block consists in the injection of Ropivacaine (20ml, 0.5%), in the anatomical plane between the Erector Spinae muscles and transverse process, laterally to the spinous process of T5 . The catheter was inserted and secured in place under ecographic guidance, and a patient-controlled regional anesthesia regimen was conducted with 0.2% ropivacaine. |
Timeline
- Start date
- 2018-09-27
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
- First posted
- 2018-09-24
- Last updated
- 2019-03-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03682354. Inclusion in this directory is not an endorsement.